Related Experiment Videos

Expression of granzyme B and perforin in multiple myeloma

I Xagoraris1, G Paterakis, B Zolota

  • 1Experimental Haematology and Transfusion Medicine, Medical School, University of Patras, Patras, Greece.

Acta Haematologica
|July 21, 2001
PubMed

Insights

Multiple myeloma tumor cells can suppress the immune system. Researchers discovered these cells express cytotoxic enzymes, potentially enabling them to destroy immune effector cells.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Multiple myeloma (MM) is an incurable blood cancer.
  • MM tumor cells employ immunosuppressive strategies, releasing agents like TGF-beta, FasL, VEGF, and Muc-1 to evade immune detection.
  • Conventional therapies have limited efficacy against MM progression.

Observation:

  • Bone marrow cells from an MM patient (IgG/k type, stage IIIA) were cultured.
  • These cultured cells exhibited expression of granzyme B and perforin.
  • Phenotypic analysis identified the cells as activated antigen-presenting cells with natural killer (NK) cell targeting capabilities.

Findings:

  • The expression of granzyme B and perforin, typically found in cytotoxic T lymphocytes (CTLs) and NK cells, was observed in cultured MM cells.
  • This suggests an unexpected cytotoxic potential within the MM tumor cells themselves.

Implications:

  • The expression of cytolytic enzymes by MM cells may represent a novel mechanism for tumor cells to actively eliminate host immune effector cells.
  • This finding could open new avenues for understanding MM pathogenesis and developing targeted immunotherapies.
  • Further research is warranted to elucidate the precise role and regulation of these enzymes in the MM tumor microenvironment.

Related Concept Videos